TOP TEN perturbations for 1554241_at (Homo sapiens)

Organism: Homo sapiens
Gene: 1554241_at
Selected probe(set): 1554241_at
Platform: Affymetrix Human Genome U133 Plus 2.0 Array

Expression of 1554241_at (1554241_at) across 6622 perturbations tested by GENEVESTIGATOR:

zalypsis study 2 / untreated OPM1 cell sample

Relative Expression (log2-ratio):-3.2149096
Number of Samples:2 / 2
Experimental zalypsis study 2
OPM1 multiple myeloma cells treated in vitro with zalypsis (5 nM), a novel marine-derived compound with potent antimyeloma activity. Cells were harvested at the beginning of induction of cell death (15-20% cell death as assessed by Annexin V-FITC staining). ATC code:---
Control untreated OPM1 cell sample
OPM1 multiple myeloma cells untreated.

normal skeletal muscle tissue (pre-training; active) / normal skeletal muscle tissue (pre-training; sedentary)

Relative Expression (log2-ratio):-2.7375402
Number of Samples:17 / 24
Experimental normal skeletal muscle tissue (pre-training; active)
Vastus lateralis muscle tissue biopsy samples from 17 young healthy active Caucasian men. Resting skeletal muscle biopsies were taken before the endurance training program. Average parameters of patients were: age=29±6 y, height=1.82±0.5 m, body mass=81.8±9 kg, VO2max=4.1±0.5 L.min-1.
Control normal skeletal muscle tissue (pre-training; sedentary)
Vastus lateralis muscle tissue biopsy samples from 24 young sedentary healthy Caucasian men. Resting skeletal muscle biopsies were taken before the endurance training program. Average parameters of patients were: age=23±1 y, height=1.82±0.02 m, body mass=78.6±2.7 kg, VO2max=3.71±0.55 L.min-1.

pediatric septic shock study 3 (infant; subclass C) / pediatric septic shock study 3 (infant)

Relative Expression (log2-ratio):2.6132784
Number of Samples:9 / 30
Experimental pediatric septic shock study 3 (infant; subclass C)
Whole blood samples obtained from infants (1 month – 1 year) with septic shock subclass C. The samples were obtained within 24 hours of admission to the pediatric intensive care unit. All children survived. The subclass C was defined based on an empiric, discovery oriented expression filter and unsupervised hierarchical clustering. Patients from subclass C (when all age groups were pooled) had an illness severity level (PRISM III score) 15 (intra-quartile range (IQR) 10.7 - 19.2), maximum number of organ failures 2 (IQR 2 - 2), and a low mortality rate.
Control pediatric septic shock study 3 (infant)
Whole blood obtained from infants (1 month – 1 year) with septic shock. The samples were obtained within 24 hours of admission to the pediatric intensive care unit (day 1). Five children did not survive.

pediatric septic shock study 3 (toddler; subclass B) / pediatric septic shock study 3 (toddler)

Relative Expression (log2-ratio):2.58461
Number of Samples:15 / 23
Experimental pediatric septic shock study 3 (toddler; subclass B)
Whole blood samples obtained from toddlers (2 – 5 years) with septic shock subclass B. The samples were obtained within 24 hours of admission to the pediatric intensive care unit. Two children did not survive. The subclass B was defined based on an empiric, discovery oriented expression filter and unsupervised hierarchical clustering. Patients in subclass B (when all age groups were pooled) had an illness severity level (PRISM III score) 15 (intra-quartile range (IQR) 10.0 - 21.0), maximum number of organ failures 2 (IQR 2 - 3), and an intermediate mortality rate. A significantly greater proportion of patients in subclass B received hydrocortisone for cardiovascular shock.
Control pediatric septic shock study 3 (toddler)
Whole blood obtained from toddlers (2 – 5 years) with septic shock. The samples were obtained within 24 hours of admission to the pediatric intensive care unit (day 1). Two children did not survive.

pediatric septic shock study 3 (toddler; subclass C) / pediatric septic shock study 3 (toddler)

Relative Expression (log2-ratio):2.4285812
Number of Samples:14 / 23
Experimental pediatric septic shock study 3 (toddler; subclass C)
Whole blood samples obtained from toddlers (2 – 5 years) with septic shock subclass C. The samples were obtained within 24 hours of admission to the pediatric intensive care unit. One child did not survive. The subclass C was defined based on an empiric, discovery oriented expression filter and unsupervised hierarchical clustering. Patients from subclass C (when all age groups were pooled) had an illness severity level (PRISM III score) 15 (intra-quartile range (IQR) 10.7 - 19.2), maximum number of organ failures 2 (IQR 2 - 2), and a low mortality rate.
Control pediatric septic shock study 3 (toddler)
Whole blood obtained from toddlers (2 – 5 years) with septic shock. The samples were obtained within 24 hours of admission to the pediatric intensive care unit (day 1). Two children did not survive.

influenza virus study 9 (A/H9N2) / influenza virus study 9 (A/pH1N1)

Relative Expression (log2-ratio):2.411725
Number of Samples:3 / 3
Experimental influenza virus study 9 (A/H9N2)
Human carcinoma cell line A549 infected with influenza A virus subtype A/Duck/Malaysia/01 (H9N2). Samples were taken 10 hours post-infection.
Control influenza virus study 9 (A/pH1N1)
Human carcinoma cell line A549 infected with influenza A virus subtype [A/Singapore/478/2009 (pH1N1)]. Samples were taken 10 hours post-infection.

echinomycin study 1 / deferoxamine study 5

Relative Expression (log2-ratio):-2.360201
Number of Samples:3 / 3
Experimental echinomycin study 1
Echinomycin (100nM; 2h) treated human astroglioma (U251) cells, stimulated with deferoxamine (DFO; 300mM; 16h). ATC code:---
Control deferoxamine study 5
Untreated human astroglioma (U251) cells, stimulated with deferoxamine (DFO; 300mM; 16h). ATC code:

influenza virus study 7 (A/H5N2) / influenza virus study 7 (A/pH1N1)

Relative Expression (log2-ratio):2.3064327
Number of Samples:3 / 3
Experimental influenza virus study 7 (A/H5N2)
Human carcinoma cell line A549 infected with influenza A virus subtype A/duck/Malaysia/F118/08/2004(H5N2). Samples were taken 6 hours post-infection.
Control influenza virus study 7 (A/pH1N1)
Human carcinoma cell line A549 infected with influenza A virus subtype [A/Singapore/478/2009 (pH1N1)]. Samples were taken 6 hours post-infection.

pediatric septic shock study 3 (school-age; subclass B) / pediatric septic shock study 3 (school-age)

Relative Expression (log2-ratio):2.291769
Number of Samples:17 / 22
Experimental pediatric septic shock study 3 (school-age; subclass B)
Whole blood samples obtained from school-age children (≥ 6 years) with septic shock subclass B. The samples were obtained within 24 hours of admission to the pediatric intensive care unit. Two children did not survive. The subclass B was defined based on an empiric, discovery oriented expression filter and unsupervised hierarchical clustering. Patients in subclass B (when all age groups were pooled) had an illness severity level (PRISM III score) 15 (intra-quartile range (IQR) 10.0 - 21.0), maximum number of organ failures 2 (IQR 2 - 3), and an intermediate mortality rate. A significantly greater proportion of patients in subclass B received hydrocortisone for cardiovascular shock.
Control pediatric septic shock study 3 (school-age)
Whole blood obtained from scholar age children (> 6 years of age) with septic shock. The samples were obtained within 24 hours of admission to the pediatric intensive care unit. To determine survival rate, patients were followed for 28 days.

diabetes type 1 study 7 / normal blood sample

Relative Expression (log2-ratio):2.2897444
Number of Samples:3 / 16
Experimental diabetes type 1 study 7
Whole blood samples from longitudinal study of children presenting with type 1 diabetes (T1D) -associated autoantibodies, who were classified with T1D at this point; T1D present at first-degree relatives.
Control normal blood sample
Whole blood sample from children persistently negative for type 1 diabetes autoantibodies. The subjects were matched for gender, age and HLA-genotype.